| ONTX |
Onconova Therapeutics, Inc. |
07 Feb 2022 |
2 |
$0 |
4 |
SVP Corp Dev & Gen Counsel |
09 Feb 2022, 15:38 |
| ONTX |
Onconova Therapeutics, Inc. |
28 Jan 2022 |
1 |
+$2,505 |
4 |
SVP Corp Dev & Gen Counsel |
31 Jan 2022, 07:41 |
| ONTX |
Onconova Therapeutics, Inc. |
21 Jan 2022 |
1 |
+$3,030 |
4 |
SVP Corp Dev & Gen Counsel |
24 Jan 2022, 07:40 |
| ONTX |
Onconova Therapeutics, Inc. |
14 Jan 2022 |
1 |
+$3,300 |
4 |
SVP CORP DEV & GEN COUNSEL |
18 Jan 2022, 08:12 |
| ONTX |
Onconova Therapeutics, Inc. |
07 Jan 2022 |
1 |
+$3,585 |
4 |
SVP Corp Dev & Gen Counsel |
10 Jan 2022, 07:39 |
| ONTX |
Onconova Therapeutics, Inc. |
19 Nov 2021 |
1 |
+$3,160 |
4 |
SVP CORP DEV & GEN COUNSEL |
23 Nov 2021, 08:20 |
| ONTX |
Onconova Therapeutics, Inc. |
18 Nov 2021 |
2 |
+$15,000 |
4 |
SVP Corp Dev & Gen Counsel |
19 Nov 2021, 07:45 |
| ONTX |
Onconova Therapeutics, Inc. |
28 Sep 2021 |
1 |
+$10,000 |
4 |
SVP Corp Dev & Gen Counsel |
29 Sep 2021, 08:27 |
| ONTX |
Onconova Therapeutics, Inc. |
02 Aug 2021 |
2 |
$0 |
4 |
SVP Corp Dev & Gen Counsel |
04 Aug 2021, 19:12 |